ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
⏸️ Investing
5 ASX shares to build a portfolio around
Growth Shares
3 healthcare shares that I want in my portfolio
Share Gainers
Cochlear Limited (ASX: COH) share price jumps on broker upgrade
Growth Shares
Where I would invest $5,000 into the share market
Share Market News
5 things to watch on the ASX 200 on Thursday
Share Fallers
Why Cochlear Limited just invested $24 million in a sleep apnea treatment business
Share Market News
4 big stories that affected the ASX 200 (ASX:XJO) this week
Share Gainers
Why UBS thinks this is the time to buy CSL Limited (ASX:CSL) shares
Growth Shares
Where I would invest $10,000 in the share market today
Share Market News
5 things to watch on the ASX 200 on Wednesday
Share Market News
ALL ORDINARIES finishes higher Tuesday: 8 shares you missed
Share Market News
ResMed Inc. (ASX:RMD) announces US$750 million SaaS acquisition: Should you invest?
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
